Artemis Investment Management LLP cut its position in Agilent Technologies, Inc. (NYSE:A) by 2.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 214,311 shares of the medical research company’s stock after selling 6,023 shares during the period. Artemis Investment Management LLP owned 0.07% of Agilent Technologies worth $13,760,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently made changes to their positions in A. Jennison Associates LLC purchased a new position in shares of Agilent Technologies in the 2nd quarter valued at $212,000. Commerce Bank purchased a new position in shares of Agilent Technologies in the 2nd quarter valued at $1,242,000. Delta Lloyd Asset Management N.V. purchased a new position in shares of Agilent Technologies in the 2nd quarter valued at $2,026,000. Prudential Financial Inc. grew its position in shares of Agilent Technologies by 2.5% in the 2nd quarter. Prudential Financial Inc. now owns 457,503 shares of the medical research company’s stock valued at $27,134,000 after buying an additional 11,020 shares during the last quarter. Finally, Cipher Capital LP grew its position in shares of Agilent Technologies by 18.1% in the 2nd quarter. Cipher Capital LP now owns 89,523 shares of the medical research company’s stock valued at $5,309,000 after buying an additional 13,703 shares during the last quarter.

A number of brokerages recently weighed in on A. Zacks Investment Research cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Monday. Robert W. Baird reiterated a “buy” rating and set a $70.00 price target on shares of Agilent Technologies in a research note on Friday, October 20th. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $68.00 price target on shares of Agilent Technologies in a research note on Tuesday, September 26th. Cowen and Company reiterated a “hold” rating and set a $65.00 price target on shares of Agilent Technologies in a research note on Thursday, September 28th. Finally, Bank of America Corporation increased their price target on shares of Agilent Technologies from $66.00 to $68.00 and gave the stock an “equal weight” rating in a research note on Wednesday, August 16th. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Agilent Technologies currently has a consensus rating of “Buy” and a consensus target price of $65.78.

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 16,492 shares of the company’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $65.33, for a total value of $1,077,422.36. Following the completion of the sale, the chief executive officer now directly owns 211,872 shares of the company’s stock, valued at approximately $13,841,597.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Didier Hirsch sold 72,545 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $62.38, for a total transaction of $4,525,357.10. The disclosure for this sale can be found here. Insiders sold 165,720 shares of company stock valued at $10,488,739 in the last ninety days.

ILLEGAL ACTIVITY WARNING: This news story was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://www.watchlistnews.com/agilent-technologies-inc-a-holdings-lowered-by-artemis-investment-management-llp/1675789.html.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.07. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.49 earnings per share.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 25th. Investors of record on Tuesday, October 3rd were issued a $0.132 dividend. This represents a $0.53 annualized dividend and a yield of 0.77%. The ex-dividend date was Monday, October 2nd. Agilent Technologies’s payout ratio is currently 27.32%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.